Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
SUPN
$48.27
+2.38%
SUPN · Supernus Pharmaceuticals, Inc.
$48.27
+1.12 (+2.38%)
At close · Aug 14
Market Cap
$2.81B
Shares
58.13M
All earnings calls
Earnings call · FY2024 Q1
Supernus Pharmaceuticals, Inc. Q1 FY2024 Earnings Call
Supernus Pharmaceuticals, Inc. Q1 FY2024 Earnings Call
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue
$143.64M
-6.6% YoY
Diluted EPS
$0.00
-100% YoY
Net income
$124,000
-99.3% YoY
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Apr 24, 2024 · complete as-filed document
SEC periodic report
10-Q report
Filed May 8, 2024 · complete as-filed document